Diagnosis and Management of Leprosy


  • hendra T UNILA




Leprosy, Morbus Hansen, Mycobacterium Leprae


Leprosy or Morbus Hansen or lepra is a chronic infectious disease caused by the bacillus Mycobacterium leprae. Leprosy attacks the peripheral nerves, skin, and other body tissues except the central nervous system. Mycobacterium leprae reproduces slowly and the average disease incubation period is 5 years. Symptoms can occur within 1 year but can also last for 20 years or even more. This disease can be cured with multidrug therapy. Kusta is likely transmitted by droplets, from the nose and mouth, during close and frequent contact with untreated cases. Diagnosis of leprosy is based on clinical, bacterioscopic, histopathological, and serological features. Of the three, clinical diagnosis is the most important and the simplest. Determination of the type of leprosy needs to be done in order to determine the appropriate therapy. In several provinces in Indonesia, the prevalence of Leprosy is still above 1 per 10,000 population where this figure cannot be declared free of Morbus Hansen and occurs in 10 provinces in Indonesia. Kusta sufferers not only suffer because of their illness but also suffer psychological impacts because people think that Leprosy is a hereditary disease. Based on the description, it is necessary to explore and know about the definition, etiology, pathogenesis, clinical manifestations, investigations, complications, management, and prognosis of Leprosy.


Aseffa A, Brennan P, Dockrell H, Gillis T, Hussain R, Oskam L, Richardus JH. 2004. Ideal Consortium. Report on the first meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held at Armauer Hansen Research Institute, ALERT, Addis Ababa, Ethiopia. 76(2):147-59.

Bhandari J, Awais M, Robbins BA, et al. Leprosy. [Updated 2021 Nov 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.

Bolognia JL Schaffer JV and Cerroni L. 2017. Dermatology. Edisi 4. Elsevier.


InfoDatin, 2018. Hapuskan Stigma dan Diskriminasi Terhadap Kusta. Infodatin Pusat Data dan Informasi Kemenkes Kesehatan RI.

James W, Berger T, Elston D, Neuhaus I. 2016. Andrews Disease of The Skin. Edisi 12. Elsevier. Philadelphia.

Jopling’s. 2020. Jopling’s Handbook of Leprosy. Edisi 6. CBS. New Delhi.

Kang S, Amogai M, Bruckner A, Enk A, Margolis D, McMichael A, et al. 2019.

Fitzpatrick’s Dermatology. Edisi 9. New York. McGraw Hills Education.P.2009.IdealConsortium Partners. Characterisation of short tandem repeats for genotyping Mycobacterium leprae. 80(3):250-60.

Lastoria JC dan Abreu. 2014. Leprosy: Review of the Epidemiological, Clinical, and Etiopathogenic aspects Part 1. Anais Brasileiros de Dermatological. 89(2): 205-218.

Misch E dan Berrington W. 2010. Leprosy and Human Genom. Microbiology and Molecular Biology Revies. 74(4):589-620.

PERDOSKI (2017) Panduan Praktik Klinis Bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta: PERDOSKI.

Prakash C dan Bhat RM. 2012. Leprosy: An Overview of Pathophysiology. Interdiscip Perspect Infect Dis. 2012; 2012: 181089.

Siregar RS. 2004. Atlas Berwarna Saripati Kulit. Edisi 2. EGC. Palembang. Smith WC. 2010. Leprosy. BMJ Clin Evid. 2010: 0915.

Silva EA, Iyer A, Ura S, Lauris JR, Naafs B, Das PK, Vilani-Moreno F. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Trop Med Int Health. 2007 Dec;12(12):1450-8.

Wisnu I, Dalili ES, Menaldi SL. 2016. Ilmu Penyakit Kulit dan Kelamin. Edisi 7.

FKUI. Jakarta.

World Health Organization. 2022. Leprosy. Diunduh dari https://www.who.int/news- room/fact-sheets/detail/leprosy 11 Februari 2022.



How to Cite

hendra T. (2022). Diagnosis and Management of Leprosy . Medical Profession Journal of Lampung, 11(2), 247-250. https://doi.org/10.53089/medula.v11i2.445




Similar Articles

You may also start an advanced similarity search for this article.